Midwest Trust’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.68M Sell
14,708
-3,210
-18% -$1.76M 0.09% 175
2026
Q2
$9.43M Sell
17,918
-106
-0.6% -$59.5K 0.11% 159
2026
Q1
$10.1M Buy
18,024
+274
+2% +$176K 0.13% 151
2025
Q4
$12M Buy
17,750
+3,969
+29% +$2.7M 0.15% 135
2025
Q3
$8.8M Buy
13,781
+12,179
+760% +$7.39M 0.11% 160
2025
Q2
$859K Buy
+1,602
New +$766K 0.01% 359

Other funds holding IDXX

Midwest Trust's IDXX Position: Q3 2026 in Review

Midwest Trust reduced its Idexx Laboratories (IDXX) stake by 18% in Q3 2026, selling an estimated $1.76M and leaving 14,708 shares worth $7.68M. The position accounts for 0.09% of the portfolio, ranked #175.

Midwest Trust first reported a position in IDXX in Q2 2025 and has held it in 6 quarters since. The position peaked at $12M in Q4 2025. 804 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Midwest Trust held 14,708 shares of Idexx Laboratories worth $7.68M as of Q3 2026.
  • Midwest Trust sold 3,210 Idexx Laboratories shares in Q3 2026, an estimated $1.76M.
  • Idexx Laboratories made up 0.09% of Midwest Trust's portfolio in Q3 2026, its #175 holding.
  • Midwest Trust first reported a position in Idexx Laboratories in Q2 2025 and has held it in 6 quarters since.
  • Midwest Trust's Idexx Laboratories position peaked at $12M in Q4 2025.
  • 804 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Midwest Trust's 13F filing for Q3 2026, filed 22 Oct 2026.